Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMR-687 in Adult Sickle Cell Anaemia
NCT03401112Phase 2Completed
- Sponsor
- Cardurion Pharmaceuticals
- Start
- Jan 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tovinontrine in sickle cell anemia (SCA), sponsored by Cardurion Pharmaceuticals. Started Jan 2018; status: completed.
02
Drugs
tovinontrine
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03401112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401112.